Search Results for keywords:"hearing request"

The Securities and Exchange Commission (SEC) has issued a notice regarding an application for an exemption under the Investment Company Act of 1940. The application involves the Optimize Growth Equity Fund, Optimize Premium Yield Fund, and Optimize Wealth Management Inc., seeking permission for certain registered closed-end investment companies to make repurchase offers monthly. If someone wishes to contest this application or request a hearing, they must submit their request to the SEC by May 6, 2025. The application details and conditions are available through the SEC's EDGAR system.

The Securities and Exchange Commission (SEC) received an application from several investment companies, including Wilshire Private Assets Fund and others, for an order permitting them to co-invest in portfolio companies together with some affiliated entities. This order would allow them to engage in joint transactions that are otherwise restricted by the Investment Company Act of 1940. The application was filed through late 2024 and early 2025, with the SEC considering issuing the order unless a hearing is requested by April 21, 2025. Interested parties can request a hearing by emailing the SEC's Secretary and should provide specific reasons for their request.

Patheon API Manufacturing, Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances. The company intends to produce these substances as Active Pharmaceutical Ingredients (APIs) for its customers, specifically focusing on synthetic tetrahydrocannabinols. The public, including existing manufacturers and applicants, may submit comments or request a hearing on this application by April 20, 2021.

Invizyne Technologies, Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances, including synthetic Tetrahydrocannabinols. Stakeholders, such as current manufacturers and applicants, can submit comments or objections electronically through the Federal eRulemaking Portal by March 24, 2025, and may also request a hearing by the same date. The DEA has provided detailed instructions for submitting comments online and has assured that comments will receive a Comment Tracking Number upon successful submission.

The Securities and Exchange Commission (SEC) has released a notice regarding an application for exemption requested by Jefferies Credit Management LLC and Jefferies Credit Partners BDC Inc. The applicants seek permission to allow certain registered closed-end investment companies to issue multiple classes of shares with different sales loads and fees. This notice provides information on how individuals can request a hearing regarding the application. Any hearing requests must be submitted to the SEC by April 8, 2025.

The Securities and Exchange Commission (SEC) has announced a notice of applications for deregistration under Section 8(f) of the Investment Company Act of 1940 for January 2025. Various investment companies, including American Maturity Life Insurance Co Separate Account One and Aquila Funds Trust, have applied to cease being classified as investment companies. Some applicants, like Aquila Funds Trust and DriveWealth ETF Trust, have already distributed funds to shareholders and covered expenses through their advisers. Individuals can request a hearing on these applications by February 25, 2025, by contacting the SEC.

Chattem Chemicals has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of controlled substances. The application, filed on July 20, 2020, lists substances like Marihuana and Tetrahydrocannabinols, which the company plans to create synthetically for distribution and sale. Interested parties can submit comments or request a hearing on this application by April 26, 2021. Written comments should be sent to the DEA in Springfield, Virginia.

The Securities and Exchange Commission (SEC) has issued a notice regarding an application from Hamilton Lane Private Assets Fund and related entities. The applicants seek permission for certain investment companies to pay advisory fees using shares of their own common stock. The public can request a hearing on this matter by contacting the SEC by December 20, 2024. Details of the application, including its legal analysis and conditions, are available on the SEC's website.

The U.S. Nuclear Regulatory Commission (NRC) is considering a change to the operating license for Florida Power and Light Company's Turkey Point Nuclear Generating Unit No. 4. This amendment would delay the installation of new reactor coolant pump seals from spring 2025 to spring 2027 due to unexpected fabrication delays. The NRC has preliminarily determined that this change does not pose significant safety risks and is accepting public comments until March 21, 2025. Requests for a hearing or petitions to intervene can be filed by April 21, 2025.

The Securities and Exchange Commission (SEC) published a notice about an application by Goldman Sachs Private Credit Corp. and Goldman Sachs Asset Management, L.P. The applicants are seeking an exemption from certain sections of the Investment Company Act of 1940 to allow certain registered closed-end investment companies to issue different classes of shares with varying fees. The SEC indicates that unless a hearing is requested by April 14, 2025, an order granting the requested relief will be issued. Interested parties can find more details by accessing the applicant's amended application on the SEC's EDGAR system.